These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7570134)

  • 21. Multicenter study to assess the in vitro activity of tigecycline by disk diffusion test against clinical isolates from Argentina.
    Fernández Canigia L; Kaufman S; Lanata L; Vay C; Giovanakis M; Bantar C;
    Chemotherapy; 2009; 55(1):20-7. PubMed ID: 18974645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changing bacterial isolates and antibiotic sensitivities of purulent dacryocystitis.
    Briscoe D; Rubowitz A; Assia E
    Orbit; 2005 Mar; 24(1):29-32. PubMed ID: 15764113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
    Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR
    J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [In vitro susceptibility patterns of bacterial species isolated in outpatients of the Metropolitan Región, Chile, year 2007].
    Camponovo C R
    Rev Chilena Infectol; 2009 Feb; 26(1):18-20. PubMed ID: 19350154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sensitivity of bacteria to antibiotics (Zurich, 2000)].
    Zbinden R; Pfyffer GE; Wüst J
    Praxis (Bern 1994); 2001 Dec; 90(50):2205-16. PubMed ID: 11793839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004).
    Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):195-201. PubMed ID: 16105564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001).
    Streit JM; Jones RN; Sader HS; Fritsche TR
    Int J Antimicrob Agents; 2004 Aug; 24(2):111-8. PubMed ID: 15288308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occurrence of antimicrobial resistance in bacteria from diagnostic samples from dogs.
    Pedersen K; Pedersen K; Jensen H; Finster K; Jensen VF; Heuer OE
    J Antimicrob Chemother; 2007 Oct; 60(4):775-81. PubMed ID: 17644533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and antibiotic susceptibility pattern of bacterial isolates from blood culture in Tikur Anbassa Hospital, Addis Ababa, Ethiopia.
    Asrat D; Amanuel YW
    Ethiop Med J; 2001 Apr; 39(2):97-104. PubMed ID: 11501295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in Antananarivo, Madagascar.
    Randrianirina F; Soares JL; Carod JF; Ratsima E; Thonnier V; Combe P; Grosjean P; Talarmin A
    J Antimicrob Chemother; 2007 Feb; 59(2):309-12. PubMed ID: 17138569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003.
    Wu CJ; Lee HC; Lee NY; Shih HI; Ko NY; Wang LR; Ko WC
    J Microbiol Immunol Infect; 2006 Apr; 39(2):135-43. PubMed ID: 16604246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacterial pathogens and their antimicrobial susceptibility in Kumasi, Ghana.
    Ohene A
    East Afr Med J; 1997 Jul; 74(7):450-5. PubMed ID: 9491183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Profile of antimicrobial resistance of agents causing urinary tract infections in Chilean children. PRONARES surveillance program].
    Prado V; Trucco O; Durán C; Mamani R; Royer M;
    Rev Med Chil; 2001 Aug; 129(8):877-85. PubMed ID: 11680961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance patterns among selective Gram-negative bacilli from an intensive care unit in Trinidad, West Indies.
    Orrett FA
    Saudi Med J; 2004 Apr; 25(4):478-83. PubMed ID: 15083220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Distribution and drug-resistance of 3 500 gram-negative bacteria in Guangzhou].
    Xiao QZ; Su DH; Jiang JH; Zhong NS
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):132-8. PubMed ID: 15698988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
    Chen MJ; Wang H;
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):375-81. PubMed ID: 12820912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial resistance of Gram-negative bacilli isolates from inpatients and outpatients at Yaounde Central Hospital, Cameroon.
    Piéboji JG; Koulla-Shiro S; Ngassam P; Adiogo D; Njine T; Ndumbe P
    Int J Infect Dis; 2004 May; 8(3):147-54. PubMed ID: 15109589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002).
    Biedenbach DJ; Moet GJ; Jones RN
    Diagn Microbiol Infect Dis; 2004 Sep; 50(1):59-69. PubMed ID: 15380279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current status of drug resistance among gram-negative bacilli isolated from admitted cases in a tertiary care centre.
    Chitnis SV; Chitnis V; Sharma N; Chitnis DS
    J Assoc Physicians India; 2003 Jan; 51():28-32. PubMed ID: 12693450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial susceptibility of clinical isolates from earthquake victims in Wenchuan.
    Kang M; Xie Y; Mintao C; Chen Z; Chen H; Fan H; Chen W; Guo X
    Clin Microbiol Infect; 2009 Jan; 15(1):87-92. PubMed ID: 19220339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.